These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8399627)

  • 1. Hyperlipemia in CAPD.
    Atkins RC; Wood C
    Perit Dial Int; 1993; 13 Suppl 2():S415-7. PubMed ID: 8399627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormality of lipid metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Saito E; Matsuda N; Tanahashi Y; Makise J; Kanayama M
    Rinsho Byori; 1986 Sep; 34(9):1083-7. PubMed ID: 3795543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dyslipidemia in renal failure].
    Fujioka T; Ueno T; Matsumoto T; Watanabe H
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():118-23. PubMed ID: 15250280
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis.
    Lameire N; Bernaert P; Lambert MC; Vijt D
    Kidney Int Suppl; 1994 Dec; 48():S31-8. PubMed ID: 7700039
    [No Abstract]   [Full Text] [Related]  

  • 5. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis.
    Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI
    Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low seroconversion rates in CAPD patients compared to hemodialysis patients: potential advantages for transplant candidates.
    Akpolat T; Dilek M; Yavuz M; Utas C; Ozener C; Karayaylali I; Yilmaz E; Ersoy F; Camsari T; Ataman R; Bozfakioglu S; Akcicek F; Ates K; Arinsoy T;
    Perit Dial Int; 2002; 22(4):520-3. PubMed ID: 12322827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects on simvastatin in continuous ambulatory peritoneal dialysis patients with hyperlipidemia].
    Zhu XP; Li J; Liu FY; Liu YH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):154-6. PubMed ID: 12212206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?
    Bergström J; Lindholm B
    Kidney Int Suppl; 1993 Feb; 40():S39-50. PubMed ID: 8445837
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of malnutrition in low-income Mexican CAPD patients.
    Garcia-Garcia G; Nuñez-Martinez MG; Obrador GT
    Perit Dial Int; 2003; 23(5):501-4. PubMed ID: 14604206
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular problems in the choice of dialysis therapy for the elderly.
    Maiorca R
    Contrib Nephrol; 1994; 106():74-83. PubMed ID: 8174382
    [No Abstract]   [Full Text] [Related]  

  • 11. Major and minor risk factors for cardiovascular disease in continuous ambulatory peritoneal dialysis patients.
    Prichard S
    Perit Dial Int; 1999; 19 Suppl 2():S133-7. PubMed ID: 10406507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of lipid profiles in long-term peritoneal dialysis.
    Olivares J; Cruz C; Gas JM; Prados MC; Perdiguero M; Caparros G; Santiago C; Franco A
    Adv Perit Dial; 1992; 8():373-5. PubMed ID: 1361826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous ambulatory peritoneal dialysis (CAPD) or center hemodialysis? Retrospective evaluation of the success of both methods.
    Marichal JF; Cordier B; Faller B; Brignon P
    Perit Dial Int; 1990; 10(3):205-8. PubMed ID: 2094459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of continuous ambulatory peritoneal dialysis and center hemodialysis. Efficacy, complications, and outcome in the treatment of end-stage renal disease.
    Charytan C; Spinowitz BS; Galler M
    Arch Intern Med; 1986 Jun; 146(6):1138-43. PubMed ID: 3718101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.
    Steele J; Billington T; Janus E; Moran J
    Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renaissance of tuberculosis in the 1990s: lessons for the nephrologist.
    Vas SI
    Perit Dial Int; 1994; 14(3):209-14. PubMed ID: 7948229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carpal tunnel syndrome in dialysis patients: comparison between continuous ambulatory peritoneal dialysis and hemodialysis populations.
    Benz RL; Siegfried JW; Teehan BP
    Am J Kidney Dis; 1988 Jun; 11(6):473-6. PubMed ID: 3376931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.
    Cattran DC; Fenton SS; Wilson DR; Steiner G
    Ann Intern Med; 1976 Jul; 85(1):29-33. PubMed ID: 937920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.